| stimulant |
drug |
10 |
3 |
Stimulants, stimulant, stimulant abusers, stimulant drugs |
| stimulant dependence |
phenotype |
11 |
7 |
stimulant abusers, stimulant users, use/dependence on stimulants |
| stimulants |
drug |
28 |
10 |
psychostimulants, stimulant use, stimulants |
| stimulus processing |
phenotype |
4 |
2 |
|
| STK11 |
gene |
3 |
2 |
LKB1, liver kinase B1 |
| STR |
cohort |
2 |
2 |
|
| streptomycin |
drug |
8 |
1 |
|
| stress |
phenotype |
62 |
43 |
Maternal separation, Noise stress, acute stress, chronic mild unpredictable stress, chronic stressors, developmental stress, distress, early stress, environmental stress, level of stress, life stress, major stressful life events, restraint stress, severe stress, stress, stress component, stress exposure, stress generation, stress in general, stress response, stressful, stressful event, stressful events, stressful experiences, stressful life events, stressors, traumatic stress |
| stress exposure |
phenotype |
6 |
5 |
stress |
| stressful life events |
phenotype |
26 |
18 |
ELS, Potentially Stressful Life Events, SLE, childhood stressful life events, common stressors, cumulative stressful life events, early-life stress, environmental measures, environmental stressors, experience of life stressors, high levels of life stress, life event stress, life events, life stress, negative life events, number of past-year stressors, number of stressful life events, past year stressful life events, past‑year life stress, potentially stressful life events, stress, stress exposure, stressful events, stressful life event, stressful life events, stressful life events experienced between ages 6 months to 3 ½ years, stressful life events experienced during the narrower window of 1 ½ to 2 ½ years, stressful life events in the past 12 months, stressful life events measure, stressful life events of at least high-moderate severity, stressors |
| stress-induced reinstatement |
phenotype |
4 |
3 |
stress relapse, stress-induced reinstatement of alcohol seeking |
| stress-related disorders |
phenotype |
2 |
2 |
|
| stress response |
phenotype |
33 |
22 |
enhanced stress response, increased sensitivity to stress, individual differences in stress reactivity, stress, stress response activation, stress responses, stress-responsive mechanisms |
| stroke |
phenotype |
26 |
19 |
cerebral infarction, experimental cerebral ischemia, ischemic stroke, stroke, stroke patients |
| stromal cells |
phenotype |
2 |
2 |
|
| Stroop task |
phenotype |
6 |
4 |
Stroop, Stroop interference, Stroop task, modified Stroop task |
| structural connectivity |
phenotype |
4 |
4 |
SC, structural connectivity |
| structural MRI |
drug |
7 |
4 |
structural magnetic resonance imaging |
| structural variant |
cohort |
23 |
10 |
SV, SVs, structural variants, structural variation |
| Structure |
drug |
7 |
4 |
STRUCTURE method, Structure version 2.1 |
